Back to Journals » OncoTargets and Therapy » Volume 10

Response to crizotinib in a lung adenocarcinoma patient harboring a novel SLC34A2-ROS1 fusion variant

Total article views   HTML views PDF downloads Totals
10,750 Dovepress* 9,196+ 1,301 10,497
PubMed Central* 1,554 270 1,824
Totals 10,750 1,571 12,321
*Since 21 August 2017
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar